drugset / Trial / NCT01760109

Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection

NCT01760109 ↗

Phase 4 Completed 2000 enrolled Xiangbei Welman Pharmaceutical Co., Ltd
NaSingle-groupOpen-labelTreatment

Summary

In the proposed study, the investigators plan to evaluate the efficacy and safety of Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for the treatment of respiratory and urinary tract acute bacterial infection.

Timeline

Start
2011-07
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Piperacillin Sodium and Sulbactam Sodium Unknown — Intravenous